EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The impact of time to local tumor destruction on cancer-specific mortality in pT1a renal cell carcinoma

Nick J. Lee, Michele Nicolazzini, Federico Polverino, Leonardo Quarta, Maximilian Filzmayer, Michele Petix, Jordan A. Goyal, Nicola Longo, Gennaro Musi, Felix K.H. Chun, Alberto Briganti, Shahrokh F. Shariat und 2 weitere

Journal of Clinical Urology · 28.10.2026

DOI: 10.1177/20514158261499208 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Urology, online erschienen am 28.10.2026. Verfasst von Nick J. Lee und 13 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the impact of time to local tumor destruction > 6 months on cancer-specific mortality in patients with pT1a renal cell carcinoma.

Methods

Using the Surveillance, Epidemiology, and End Results database (2004–2022), patients with pT1aN0M0 renal cell carcinoma of 1–3 cm treated with local tumor destruction were stratified according to time to local tumor destruction (⩽ 6 vs > 6 months). Propensity score matching and multivariate competing risks regression were used. Sample power analyses were performed.

Results

Among 3528 pT1a 1–3 cm renal cell carcinoma patients, time to local tumor destruction > 6 months was recorded in 282 (8.0%) patients. After propensity score matching, patients with time to local tumor destruction > 6 months demonstrated a 60-month cancer-specific mortality rate of 10.0% versus 4.6% in patients with time to local tumor destruction ⩽ 6 months. In multivariable competing risks regression models, statistical significance was not achieved (95% confidence interval: 0.8–2.8, p = 0.24). Power analysis revealed a power of 28%. To achieve 80% power with the observed cancer-specific mortality rates, 1450 patients per arm would be required.

Conclusions

Although time to local tumor destruction > 6 months is associated with a 5.4% cancer-specific mortality increase, the present study was underpowered to identify a benefit to early treatment with local tumor destruction. In the absence of better data, a 6-month delay is acceptable when considering local tumor destruction. Level of Evidence: 3.

Zitieren

APA

Lee, N. J., Nicolazzini, M., Polverino, F., Quarta, L., Filzmayer, M., Petix, M., Goyal, J. A., Longo, N., Musi, G., Chun, F. K., Briganti, A., Shariat, S. F., Saad, F., & Karakiewicz, P. I. (2026). The impact of time to local tumor destruction on cancer-specific mortality in pT1a renal cell carcinoma. Journal of Clinical Urology. https://doi.org/10.1177/20514158261499208

Vancouver

Lee NJ, Nicolazzini M, Polverino F, Quarta L, Filzmayer M, Petix M, et al. The impact of time to local tumor destruction on cancer-specific mortality in pT1a renal cell carcinoma. Journal of Clinical Urology. 2026. doi:10.1177/20514158261499208

BibTeX
@article{Lee2026,
  author = {Lee, Nick J. and Nicolazzini, Michele and Polverino, Federico and Quarta, Leonardo and Filzmayer, Maximilian and Petix, Michele and Goyal, Jordan A. and Longo, Nicola and Musi, Gennaro and Chun, Felix K.H. and Briganti, Alberto and Shariat, Shahrokh F. and Saad, Fred and Karakiewicz, Pierre I.},
  title = {The impact of time to local tumor destruction on cancer-specific mortality in pT1a renal cell carcinoma},
  journal = {Journal of Clinical Urology},
  year = {2026},
  doi = {10.1177/20514158261499208}
}
Kostenlos starten →